Bionano Genomics, Inc. (BNGO:NASDAQ) closed at $1.19 on October 22, 2026, down 4.72% on the day. The stock trades 46.6% below its 52-week high of $2.23 and 19.1% above its 52-week low of $1.00. Over the past year, it lost 34.9%. Bionano Genomics, Inc. is part of the Capital Goods sector (Biotechnology: Laboratory Analytical Instruments).
In 252 trading sessions since October 21, 2025, BNGO closed higher on 100 days (40%). Its best day was March 23, 2026 (+26.96%) and its worst was March 24, 2026 (-19.18%). The stock moved 10% or more in a single session 5 times.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Find more stocks like BNGO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.